Financhill
Back

National Australia Bank Ltd. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
59

NABZY
National Australia Bank Ltd.

Last Price:
$13.76
Seasonality Move:
2.76%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$55.80
Seasonality Move:
-11.9%
Buy
59
National Australia Bank Ltd. (NABZY) is a Buy

Is National Australia Bank Ltd. a Buy, Sell or Hold?

  • The current National Australia Bank Ltd. [NABZY] share price is $13.82. The Score for NABZY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • NABZY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NABZY Stock Price Chart

What is National Australia Bank Ltd.'s stock price today?

  • The National Australia Bank Ltd. share price today is $13.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NABZY is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

NABZY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 46.83 Sell
Chaikin Money Flow: 55303 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.62 - 14.22) Sell
Bollinger Bands (100): (13.57 - 14.49) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

NABZY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.07 Sell
20-day SMA: 14.04 Sell
50-day SMA: 13.85 Sell
200-day SMA: 13.04 Buy
8-day EMA: 14 Sell
20-day EMA: 13.97 Sell
50-day EMA: 13.9 Sell
200-day EMA: 13.3 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

National Australia Bank Ltd. Earnings Growth & NABZY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.02 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

National Australia Bank Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):